All News

Patients with HER2-positive metastatic breast cancer may receive sufficient first-line treatment with Perjeta plus Herceptin without chemotherapy.

Geoff Grubbs, who was diagnosed with chronic lymphocytic leukemia in 2009, has undergone five lines of treatment and participated in two clinical trials.

The members of my lung cancer support group recently came up with some responses for when people ask us, "So you have lung cancer — did you smoke?"

PARP inhibitors, primarily used to treat BRCA-mutated disease, may have efficacy potential in triple negative breast cancer.

A year ago, I attended a cancer camp called Camp Make-a-Dream, and I found a specific calling: creativity in jewelry.

Social isolation has become prominent among young cancer survivors, though social connectedness may be beneficial to wellbeing, a recent study showed.

The Hepzato Kit is a direct-to-liver therapy for patients with uveal melanoma with hepatic metastases.

The Food and Drug Administration granted accelerated approval for Elrexfio for the treatment of patients with relapsed or refractory multiple myeloma who previously received at least four lines of therapy.

The countdown to my CT scan has begun.

Family history of breast and other cancers can mean some people are more likely to develop the disease at a younger age. But advances in testing may improve prevention and survival rates.

Wearable fitness devices can offer valuable insights for patients with cancer and the doctors treating them.

After a certain amount of time in the day, bras become devilish and must be removed immediately!

Using inter-arterial chemotherapy compared to intravenous chemotherapy may significantly improve globe salvage rates in children with advanced unilateral retinoblastoma.

Akeega, the first dual action tablet with a PARP inhibitor and abiraterone acetate, was approved for the treatment of patients with suspected or confirmed BRCA-positive metastatic castration-resistant prostate cancer.

A phase 1 clinical trial just launched and will test the novel agent, CLN-978, for relapsed/refractory B-cell non-Hodgkin lymphoma.

There are two different types of lung cancer — small cell and non-small cell lung cancer — that behave differently and therefore require different treatments, an expert explained.

Don’t waste your cancer.

From Jill Martin revealing an updated about her cancer to Casey DeSantis announcing breast cancer diagnosis, this is what’s happening in the oncology space this week.

Patients with metastatic clear cell renal cell carcinoma who received corticosteroids during Opdivo treatment did not experience a negative impact on survival.

There are multiple types of skin cancer and treatments to treat the disease, too, explained an expert.

The ongoing chemotherapy shortage is preventing some clinical research from happening, resulting in both short- and long-term implications for cancer care.

The importance of cascade genetic testing has led me to advocate through my artwork.

Bill C. Potts, author and five-time cancer survivor, lends his experience and tips about cancer to others in his book, “Up for the Fight.”

The FDA granted an accelerated approval for Talvey to treat patients with relapsed/refractory multiple myeloma.

Artificial intelligence platforms such as ChatGPT are offering patients a more personal and conversational way to research their cancer, an expert said.

This regular approval provides Gavreto as a treatment option for patients with metastatic RET fusion-positive non-small cell lung cancer.

“I flow, I change constantly, I am my grief, I am my joy, I am human, I am divine light, I can submerge when I make the time.” — Shosh Madick.

Patients with myelodysplastic syndrome should seek an expert opinion on their disease to ensure an accurate diagnosis and proper treatment plan.